Verdict: Overreaction

Key finding: HydroGraph ran +32% intraday on a corporate progress update that contains no new order, contract or revenue. It is a $921M company with $116K of trailing revenue, trading 42% below the C$6.80 bought deal it closed on Aug 25.

Scorecard

Ticker Rev last Q Rev YoY last Q Rev YoY prior Q Gross margin (last Q) Op margin EPS last Q vs yr ago P/S (TTM) Mkt cap 1-mo price %
HGRAF $0.045M +134.6% +122.3% negative (cost > sales) n/m -0.0124 vs -0.0100 ~7,900x $921M -23.0%
NNXPF (NanoXplore) C$33.9M +45.7% — 23.5% (up from 14.8%) -2.2% -0.0146 vs -0.0135 ~1.9x $157M -25.6%
GMGMF (Graphene Mfg Group) A$0.38M -92.0% — negative n/m -0.0581 vs -0.0325 ~440x $203M -9.2%
ZTEK (Zentek) C$0 -100% — negative n/m -0.0178 vs -0.013 ~800x $62M —
BSWGF (Black Swan Graphene) C$1.69M first revenue — negative n/m -0.0358 vs -0.0219 ~27x $32M -7.0%

HGRAF is the valuation outlier of the group: the largest market cap ($921M) on the smallest real revenue base ($116K TTM), about 6x NanoXplore's value on roughly 0.1% of its sales. Revenue is growing from a tiny base, but every graphene name except NanoXplore is still pre-commercial. Figures: FMP quarterly income statements and quotes (10/21); 1-month % vs the 9/21 close; P/S uses approximate FX.

Move

Catalyst

HydroGraph's 10/21 progress update (GlobeNewswire, StockTitan summary):

Sector

Graphene is still a pre-commercial niche: only NanoXplore in the group sells at scale (C$33.9M last quarter), and it is down 25.6% in a month. The theme has no sector ETF. Today's move is company-specific; inference: part of it is a rebound after a 60% slide rather than a reaction to new facts.

Risks

Judgement

Overreaction. The update restates plans (samples, negotiations, a 2027 plant) without a signed order, a named defense program or revenue, and pairs it with new insider equity grants. A +32% day on that is a rebound after a 60% slide, not a re-rating on new facts. A real purchase order or a named federal program would change this verdict.

Sources